Asymmetric synthesis towards doxanthrine, a dopamine D1 full agonist-Reference-Cited by-同舟云学术

Asymmetric synthesis towards doxanthrine, a dopamine D1 full agonist

Published:2014 Issue:89 Volume:4 Page:48344-48347
ISSN:2046-2069
Container-title:RSC Adv.
language:en
Short-container-title:RSC Adv.

Author:

Malhotra Rajesh¹²³,Ghosh Amit¹²³⁴⁵,Dutta Swarup⁴⁵,Dey Tushar K.¹²³⁴⁵,Basu Sourav⁴⁵,Hajra Saumen¹⁶⁷⁸⁹

Affiliation:

1. Department of Chemistry

2. Guru Jambheshwar University of Science and Technology

3. Hisar, India

4. TCG Life Sciences Ltd

5. Kolkata 700091, India

6. Indian Institute of Technology Kharagpur

7. Kharagpur 721302, India

8. Centre of Biomedical Research

9. SGPGIMS Campus

Abstract

First asymmetric synthesis of towards doxanthrine is accomplished with high diastereo- and enantioselectivity from β-aryloxyamino acid derived from D-serine.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2014/RA/C4RA06617K

Reference26 articles.

1. Adrogolide HCl (ABT-431; DAS-431), a Prodrug of the Dopamine D1 Receptor Agonist, A-86929: Preclinical Pharmacology and Clinical Data

2. Investigation of D1Receptor-Agonist Interactions and D1/D2Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling

3. Dopamine D1receptor ligands: Where are we now and where are we going

4. Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Synthesis of Dopaminergic Agonists;Current Medicinal Chemistry;2016-09-05

2. Friedel-Crafts Alkylation of Arenes in Total Synthesis;Arene Chemistry;2015-11-27